Marko Kornmann, M.D.
Professor of Surgery and Vice Chair
Department of General and Visceral Surgery
University of Ulm
Surgical oncology of gastrointestinal cancer. Translational research evaluating molecular targets as prognostic and predictive markers for GI cancer focusing on alterations of growth factor pathways. Tumor-tailored treatment of GI malignancies.
Graduation from Ulm Medical School in 1994. Experimental part of doctoral theses was performed at Prof. P.V. Danenberg?s laboratory at the Dept. of Biochemistry, University of Southern California School of Medicine, Los Angeles, CA, U.S.A. He holds a M.D. degree from the University of Ulm. Title of thesis: Relative thymidylate synthase gene expression and human tumor colony-forming assay to predict response to fluoropyrimidine based chemotherapy in colorectal cancer. Start of surgical training at the Dept. of General and Visceral Surgery (Head: Prof. H.G. Beger) at the University of Ulm in 1994. Postdoctoral training was received at the laboratory of Prof. M. Korc at the Dept. of Medicine, Biological Chemistry and Pharmacology, University of California, Irvine from 1996 to 1998. After returning to the University of Ulm residency was completed at the Dept. of General and Visceral Surgery.
Degree for General Surgery and Assistant Professor of Surgery, 2003. Written thesis: Expression of growth factors and their receptors in human pancreatic cancer and their influence on cell cycle. Oral thesis: How can enzymes of the pyrimidine metabolism influence prognosis of colorectal cancer patients. Degree for visceral surgery and full Professor of Surgery, 2006. Vice chair of the Department of General and Visceral Surgery, 2009.
Published meanwhile more 100 original research articles, reviews and book chapters in internationally recognized journals like Cancer Research, Oncogene, Journal of Clinical Investigation, Gastroenterology, Gut, or Annals of Surgery.
Conducted the largest German adjuvant trial on colon and rectal cancer as well as the first German trial using the level of a molecular marker as a stratification criteria in a randomized controlled trial in advanced colorectal cancer.
Member among others of the German Society of Surgery (DGC), German Society of General and Visceral Surgery (DGAV), European Society of Surgical Oncology (ESSO), International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), and the International Colorectal Cancer Club (ICRCC). Secretary of the working group surgical oncology of the DGAV and the ICRCC. Member of the editorial board of Langenbeck?s Archives of Surgery. Reviewer for several surgical and oncological journals.